Joint Corp/the (JYNT)

$12.28

-0.31

(-2.46%)▲

Market is closed - opens 7 PM, 25 Apr 2024

Insights on Joint Corp/the

  • Increasing Revenue

    Revenue is up for the last 15 quarters, 12.58M → 30.61M (in $), with an average increase of 6.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, 2.32M → -11.04M (in $), with an average decrease of 608.7% per quarter

  • Vs DVA

    In the last 1 year, Davita Healthcare Partners Inc. has given 53.4% return, outperforming this stock by 70.2%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 17.9% return, outperforming this stock by 94.8%

Performance

  • $12.12
    $12.58
    $12.28
    downward going graph

    1.3%

    Downside

    Day's Volatility :3.66%

    Upside

    2.38%

    downward going graph
  • $7.31
    $16.48
    $12.28
    downward going graph

    40.47%

    Downside

    52 Weeks Volatility :55.64%

    Upside

    25.49%

    downward going graph

Returns

PeriodJoint Corp/theSector (Health Care)Index (Russel 2000)
3 Months
34.08%
2.0%
0.0%
6 Months
53.54%
11.7%
0.0%
1 Year
-20.42%
5.8%
1.3%
3 Years
-76.61%
14.2%
-22.1%

Highlights

Market Capitalization
184.6M
Book Value
$1.68
Earnings Per Share (EPS)
-0.66
PEG Ratio
-0.7
Wall Street Target Price
12.19
Profit Margin
-8.29%
Operating Margin TTM
4.48%
Return On Assets TTM
0.39%
Return On Equity TTM
-34.0%
Revenue TTM
117.7M
Revenue Per Share TTM
8.01
Quarterly Revenue Growth YOY
10.6%
Gross Profit TTM
92.1M
EBITDA
9.1M
Diluted Eps TTM
-0.66
Quarterly Earnings Growth YOY
-0.77
EPS Estimate Current Year
0.04
EPS Estimate Next Year
0.39
EPS Estimate Current Quarter
0.01
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    72%Buy
    27%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Joint Corp/the(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
9
Hold
3
3
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Downside of 0.73%

Current $12.28
Target $12.19

Company Financials

FY18Y/Y Change
Revenue
31.8M
↑ 26.33%
Net Income
253.1K
↓ 107.73%
Net Profit Margin
0.8%
↑ 13.82%
FY19Y/Y Change
Revenue
48.5M
↑ 52.41%
Net Income
3.3M
↑ 1213.29%
Net Profit Margin
6.86%
↑ 6.06%
FY20Y/Y Change
Revenue
58.7M
↑ 21.12%
Net Income
13.2M
↑ 296.16%
Net Profit Margin
22.44%
↑ 15.58%
FY21Y/Y Change
Revenue
81.2M
↑ 38.36%
Net Income
7.6M
↓ 42.55%
Net Profit Margin
9.32%
↓ 13.12%
FY22Y/Y Change
Revenue
101.9M
↑ 25.52%
Net Income
1.2M
↓ 84.44%
Net Profit Margin
1.16%
↓ 8.16%
FY23Y/Y Change
Revenue
117.7M
↑ 15.49%
Net Income
-9.8M
↓ 928.39%
Net Profit Margin
-8.29%
↓ 9.45%
Q3 FY22Q/Q Change
Revenue
26.6M
↑ 6.17%
Net Income
491.1K
↑ 42.46%
Net Profit Margin
1.85%
↑ 0.47%
Q4 FY22Q/Q Change
Revenue
27.8M
↑ 4.55%
Net Income
547.2K
↑ 11.42%
Net Profit Margin
1.97%
↑ 0.12%
Q1 FY23Q/Q Change
Revenue
28.5M
↑ 2.29%
Net Income
2.3M
↑ 325.11%
Net Profit Margin
8.18%
↑ 6.21%
Q2 FY23Q/Q Change
Revenue
29.3M
↑ 3.01%
Net Income
-190.4K
↓ 108.18%
Net Profit Margin
-0.65%
↓ 8.83%
Q3 FY23Q/Q Change
Revenue
29.5M
↑ 0.57%
Net Income
-716.3K
↑ 276.23%
Net Profit Margin
-2.43%
↓ 1.78%
Q4 FY23Q/Q Change
Revenue
30.6M
↑ 3.87%
Net Income
-11.0M
↑ 1441.53%
Net Profit Margin
-36.07%
↓ 33.64%
FY18Y/Y Change
Total Assets
23.5M
↑ 39.13%
Total Liabilities
21.2M
↑ 76.21%
FY19Y/Y Change
Total Assets
43.7M
↑ 85.77%
Total Liabilities
38.0M
↑ 79.47%
FY20Y/Y Change
Total Assets
65.7M
↑ 50.4%
Total Liabilities
45.0M
↑ 18.42%
FY21Y/Y Change
Total Assets
84.0M
↑ 27.85%
Total Liabilities
54.5M
↑ 21.11%
FY22Y/Y Change
Total Assets
91.9M
↑ 9.4%
Total Liabilities
59.5M
↑ 9.3%
FY23Y/Y Change
Total Assets
87.2M
↓ 5.21%
Total Liabilities
62.4M
↑ 4.76%
Q3 FY22Q/Q Change
Total Assets
88.3M
↑ 2.38%
Total Liabilities
56.8M
↑ 1.82%
Q4 FY22Q/Q Change
Total Assets
91.9M
↑ 4.14%
Total Liabilities
59.5M
↑ 4.89%
Q1 FY23Q/Q Change
Total Assets
98.1M
↑ 6.64%
Total Liabilities
62.9M
↑ 5.72%
Q2 FY23Q/Q Change
Total Assets
99.3M
↑ 1.32%
Total Liabilities
63.7M
↑ 1.26%
Q3 FY23Q/Q Change
Total Assets
98.6M
↓ 0.78%
Total Liabilities
63.3M
↓ 0.71%
Q4 FY23Q/Q Change
Total Assets
87.2M
↓ 11.59%
Total Liabilities
62.4M
↓ 1.44%
FY18Y/Y Change
Operating Cash Flow
5.5M
↑ 3385.12%
Investing Cash Flow
-1.2M
↑ 233.55%
Financing Cash Flow
326.3K
↓ 77.07%
FY19Y/Y Change
Operating Cash Flow
7.5M
↑ 37.96%
Investing Cash Flow
-7.1M
↑ 473.96%
Financing Cash Flow
-597.0K
↓ 282.95%
FY20Y/Y Change
Operating Cash Flow
11.2M
↑ 48.67%
Investing Cash Flow
-4.6M
↓ 35.54%
Financing Cash Flow
5.6M
↓ 1037.33%
FY21Y/Y Change
Operating Cash Flow
15.2M
↑ 36.21%
Investing Cash Flow
-14.1M
↑ 207.4%
Financing Cash Flow
-2.0M
↓ 135.68%
FY22Y/Y Change
Operating Cash Flow
11.1M
↓ 27.23%
Investing Cash Flow
-20.8M
↑ 46.89%
Financing Cash Flow
328.6K
↓ 116.46%
Q3 FY22Q/Q Change
Operating Cash Flow
4.2M
↑ 314.56%
Investing Cash Flow
-3.5M
↓ 64.31%
Financing Cash Flow
239.3K
↑ 404.62%
Q4 FY22Q/Q Change
Operating Cash Flow
5.4M
↑ 28.1%
Investing Cash Flow
-5.8M
↑ 65.61%
Financing Cash Flow
16.3K
↓ 93.19%
Q1 FY23Q/Q Change
Operating Cash Flow
6.0M
↑ 11.52%
Investing Cash Flow
-1.2M
↓ 79.43%
Financing Cash Flow
129.8K
↑ 696.77%
Q2 FY23Q/Q Change
Operating Cash Flow
1.5M
↓ 75.62%
Investing Cash Flow
-2.6M
↑ 114.93%
Financing Cash Flow
57.9K
↓ 55.43%

Technicals Summary

Sell

Neutral

Buy

Joint Corp/the is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Joint Corp/the
Joint Corp/the
-1.02%
53.54%
-20.42%
-76.61%
-27.77%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
13.53%
23.8%
-7.73%
-45.32%
-46.38%
Hca Holdings, Inc.
Hca Holdings, Inc.
-2.41%
41.74%
13.28%
59.27%
156.45%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
-4.68%
74.59%
41.83%
75.13%
300.25%
Universal Health Services Inc.
Universal Health Services Inc.
-7.28%
34.94%
17.19%
13.12%
25.22%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-0.64%
65.1%
53.39%
18.14%
148.49%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Joint Corp/the
Joint Corp/the
71.28
NA
-0.7
0.04
-0.34
0.0
NA
1.68
Fresenius Medical Care Ag
Fresenius Medical Care Ag
22.58
22.58
0.39
2.02
0.05
0.03
0.03
46.42
Hca Holdings, Inc.
Hca Holdings, Inc.
16.37
16.37
1.44
20.64
0.12
0.11
0.01
-6.68
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
17.14
17.14
2.2
6.03
0.26
0.06
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
15.75
15.75
1.87
13.45
0.12
0.05
0.01
91.53
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
17.86
17.86
1.16
9.01
0.39
0.06
NA
11.89
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Joint Corp/the
Joint Corp/the
Buy
$184.6M
-27.77%
71.28
-8.29%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$12.2B
-46.38%
22.58
2.57%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$82.1B
156.45%
16.37
8.07%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$9.7B
300.25%
17.14
2.97%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$10.8B
25.22%
15.75
5.03%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$11.6B
148.49%
17.86
5.7%

Institutional Holdings

  • Bandera Partners LLC

    26.65%

  • Vanguard Group Inc

    6.98%

  • BlackRock Inc

    6.80%

  • Goldman Sachs Group Inc

    4.91%

  • Skylands Capital, LLC

    4.09%

  • D. E. Shaw & Co LP

    2.53%

Company Information

the joint was founded in tucson in 1999 by dr. fred gerretzen, whose vision was to turn the traditional and often misunderstood concept of routine chiropractic care into a simple and affordable reality. today, the joint delivers on that vision, with convenient locations nationwide whose shared purpose is to improve our patients' quality of life through routine and affordable chiropractic care. our mission. our mission is to improve quality of life through routine and affordable chiropractic care. that's why we built a nationwide network of modern, comfortable chiropractic locations staffed with experienced, licensed chiropractors. our membership plans are designed to make chiropractic care accessible, and our no-insurance-necessary approach to chiropractic care is revolutionizing the way people receive health care— putting the relationship back where it belongs, between you and your doctor. at the joint, we strive to maintain the highest quality of care and professionalism, while

Organization
Joint Corp/the
Employees
444
CEO
Mr. Peter D. Holt
Industry
Lessors of Nonfinancial Intangible Assets (except Copyrighted Works)

Discover More

FAQs